These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 4831652)

  • 1. The inotropic effects of the calcium inophore X-537A in the anesthetized dog.
    De Guzman NT; Pressman BC
    Circulation; 1974 Jun; 49(6):1072-7. PubMed ID: 4831652
    [No Abstract]   [Full Text] [Related]  

  • 2. Mode of action of the calcium ionophores X-537A and A23187 on cardiac contractility.
    Schaffer SW; Safer B; Scarpa A; Williamson JR
    Biochem Pharmacol; 1974 May; 23(11):1609-17. PubMed ID: 4847535
    [No Abstract]   [Full Text] [Related]  

  • 3. Hemodynamic responses to beta-adrenergic blockade in dogs.
    Shen Y; Quiroz AC; Burch GE; DePasquale NP
    Am Heart J; 1967 May; 73(5):669-73. PubMed ID: 4225818
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiac and metabolic effects of dibutyryl cyclic AMP in the intact dog heart and the isolated perfused rat heart.
    Dhalla NS; Chernecki W; Gandhi SS; McNamara DB; Naimark A
    Recent Adv Stud Cardiac Struct Metab; 1973; 3():233-50. PubMed ID: 4377597
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological evidence for catecholamine-independent contractile effects of X-537A on the isolated working rat heart preparation.
    Rodgers RL; Moore JI; Hornbrook KR
    Can J Physiol Pharmacol; 1979 Apr; 57(4):428-31. PubMed ID: 455144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Capacity for exercise after denervation of the heart.
    Donald DE
    Circulation; 1968 Aug; 38(2):225-6. PubMed ID: 4875290
    [No Abstract]   [Full Text] [Related]  

  • 7. Inotropic and metabolic effects of dibutyryl cyclic adenosine 3', 5'-monophosphate in the perfused rat heart.
    Ahrén K; Hjalmarson A; Isaksson O
    Acta Physiol Scand; 1971 May; 82(1):79-90. PubMed ID: 4327037
    [No Abstract]   [Full Text] [Related]  

  • 8. Glucagon. Its enhancement of cardiac performance in the cat and dog and persistence of its inotropic action despite beta-receptor blockade with propranolol.
    Glick G; Parmley WW; Wechsler AS; Sonnenblick EH
    Circ Res; 1968 Jun; 22(6):789-99. PubMed ID: 5659816
    [No Abstract]   [Full Text] [Related]  

  • 9. Influence of adrenergic beta-receptor blockade on the acute cardiovascular effects of hydralazine.
    Brunner H; Hedwall PR; Meier M
    Br J Pharmacol Chemother; 1967 May; 30(1):123-33. PubMed ID: 6039968
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiovascular and metabolic effects of cyclic adenosine 3', 5'-monophosphate in unanesthetized dogs.
    Levine RA; Vogel JA
    J Pharmacol Exp Ther; 1966 Feb; 151(2):262-72. PubMed ID: 4379816
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative effects of sotalol and propranolol on myocardial contractility.
    Gomoll AW; Braunwald E
    Arch Int Pharmacodyn Ther; 1973 Oct; 205(2):338-54. PubMed ID: 4148833
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of the effects of (plus of minus)-propranolol and (plus)-propranolol in anaesthetized dogs; beta-receptor blocking and haemodynamic action.
    Barrett AM
    J Pharm Pharmacol; 1969 Apr; 21(4):241-7. PubMed ID: 4390143
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacologic antagonism of beta-adrenergic blockade in dogs. I. Hemodynamic effects of isoproterenol, dopamine, and epinephrine in acute propranolol administration.
    Avery GJ; Spotnitz HM; Rose EA; Malm JR; Hoffman BF
    J Thorac Cardiovasc Surg; 1979 Feb; 77(2):267-76. PubMed ID: 33298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effects of amantadine on heart and circulation].
    van Ackern K; Deuster JE; Mast GJ; Schmier J
    Arzneimittelforschung; 1975 Jun; 25(6):891-6. PubMed ID: 51642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-dimethylisopropyl propranolol. Effects on myocardial oxygen demands.
    Olson EG; Goodyer AV; Langou RA; Cohen LS; Wolfson S
    Circulation; 1976 Mar; 53(3):501-5. PubMed ID: 1248083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular effects of 1,1,1-trichloroethane.
    Herd PA; Lipsky M; Martin HF
    Arch Environ Health; 1974 Apr; 28(4):227-33. PubMed ID: 4814959
    [No Abstract]   [Full Text] [Related]  

  • 17. Some cardiac metabolic and haemodynamic alterations due to adrenergic beta-receptor blockade.
    Szekeres L; Udvary E; Papp JG
    Acta Biol Med Ger; 1972; 28(6):1031-9. PubMed ID: 4404698
    [No Abstract]   [Full Text] [Related]  

  • 18. The cardiovascular pharmacology of the antibiotic ionophore Ro 2-2985 (X537A).
    Osborne MW; Wenger JJ; Zanko MT
    J Pharmacol Exp Ther; 1977 Jan; 200(1):195-206. PubMed ID: 833757
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for glucagon in cardiac therapy.
    Parmley WW; Sonnenblick EH
    Am J Med Sci; 1969 Oct; 258(4):224-9. PubMed ID: 4309903
    [No Abstract]   [Full Text] [Related]  

  • 20. Treadmill exercise in dogs under -adrenergic blockade: adaptation of coronary and systemic hemodynamics.
    Bassenge E; Kucharczyk M; Holtz J; Stoian D
    Pflugers Arch; 1972; 332(1):40-55. PubMed ID: 4401667
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.